We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » 35 Briefs Supporting FDA Submitted to U.S. Supreme Court on Mifepristone Decision
35 Briefs Supporting FDA Submitted to U.S. Supreme Court on Mifepristone Decision
Thirty-five amicus briefs on the issue of the FDA’s approval of the abortion drug mifepristone landed in the Supreme Court of U.S. on Tuesday, all in support of the FDA’s position, from submitters ranging from single associations to groups with more than 600 members.
